Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Oncology Institute (NASDAQ:TOI) raises FY2025 sales outlook from $460.000 million-$480.000 million to $495.000 million-$505.000...
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate ...
Ascertain, a healthcare technology company pioneering agentic AI to automate administrative workflows, and The Oncology Institu...
On November 3, 2025, The Oncology Institute, Inc. (the "Company") determined that a cybersecurity incident affecting an...
BTIG analyst David Larsen reiterates Oncology Institute (NASDAQ:TOI) with a Buy and maintains $7 price target.
Oncology Institute (NASDAQ:TOI) affirms FY2025 sales outlook from $460.000 million-$480.000 million to $460.000 million-$480.00...
